MAPT and Alzheimer disease: We grouped 3R/4R tau seeding doses analyzed across all cases by sex (Fig. 8) and by Braak ≤ III (absent & low/intermediate AD tau neuropathology) or Braak ≥ IV (high AD tau neuropathology).